Vimarsana
Biggest News Aggregation in the World

Page 7 - Nasdaq Bbio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bbio Today - Breaking & Trending Today

BridgeBio presents detailed positive results from Phase 3 - Vimarsana News

BridgeBio presents detailed positive results from Phase 3

- The primary endpoint was met (Win Ratio of 1.8) with a highly statistically significant p-value (p<0.0001); this primary endpoint result consistently...

Pinnacle Associates Ltd. Sells 28,750 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) - Vimarsana News

Pinnacle Associates Ltd. Sells 28,750 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Pinnacle Associates Ltd. reduced its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 66.1% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 14,750 shares of the company’s stock after selling 28,750 shares during the period. Pinnacle Associates Ltd.’s holdings in […]

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Rating of "Moderate Buy" by Brokerages - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Rating of "Moderate Buy" by Brokerages

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten analysts that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1 year […]

Contrasting Achilles Therapeutics (NASDAQ:ACHL) & BridgeBio Pharma (NASDAQ:BBIO) - Vimarsana News

Contrasting Achilles Therapeutics (NASDAQ:ACHL) & BridgeBio Pharma (NASDAQ:BBIO)

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) and Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends. Analyst Recommendations This is a breakdown of recent […]

BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $42.00 - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $42.00

BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price objective lifted by BTIG Research from $32.00 to $42.00 in a research report released on Tuesday morning, FlyOnTheWall reports. Several other research firms have also commented on BBIO. Jefferies Financial Group lowered BridgeBio Pharma from a buy rating to a hold rating and upped their target […]